How should severe hyponatremia be corrected in a patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Severe Hyponatremia (Sodium 118)

For a patient with severe hyponatremia (sodium 118), correction should be performed at a rate not exceeding 8 mEq/L in 24 hours, with careful monitoring every 2 hours to prevent osmotic demyelination syndrome. 1

Initial Assessment and Treatment Approach

For Symptomatic Severe Hyponatremia:

  • If severe neurological symptoms present (seizures, coma, severe confusion):
    • Administer 3% hypertonic saline as bolus infusion
    • Target initial increase: 4-6 mEq/L within 1-2 hours until symptoms improve 1, 2
    • Critical safety principle: Do not exceed correction of 8-10 mEq/L in 24 hours 1

For Asymptomatic or Mildly Symptomatic Hyponatremia:

  • Treatment based on volume status assessment:
    • Hypovolemic: Isotonic (0.9%) saline infusion
    • Euvolemic: Fluid restriction (<1 L/day)
    • Hypervolemic: Fluid restriction + treatment of underlying condition 1

Monitoring Protocol

  • Check serum sodium every 2 hours in severely symptomatic patients 1
  • Monitor urine output and specific gravity every 4 hours 1
  • Watch for signs of water diuresis (sudden decrease in urine specific gravity ≥0.010), which can lead to overcorrection 1

Risk Factors for Overcorrection

  1. Severe symptoms (38% vs 6% overcorrection rate compared to moderate symptoms) 1
  2. High urine output or water diuresis 1
  3. Hypovolemia that may be misinterpreted as symptomatic hyponatremia 1

Specific Management Considerations

Pharmacologic Options for Resistant Cases:

  • Tolvaptan may be considered for euvolemic or hypervolemic hyponatremia, but:
    • Must be initiated in a hospital setting
    • Requires close monitoring of serum sodium
    • Risk of too rapid correction (>12 mEq/L/24 hours) can cause osmotic demyelination 3
    • Starting dose: 15 mg once daily, may increase to 30 mg after 24 hours if needed 3
    • Avoid fluid restriction during first 24 hours of tolvaptan therapy 3

Prevention of Osmotic Demyelination Syndrome:

  • Patients with severe malnutrition, alcoholism, or advanced liver disease may require slower correction rates 1, 3
  • If correction is proceeding too rapidly, consider:
    • Administering hypotonic fluids
    • Using desmopressin to slow correction 1

Volume Status-Based Treatment Algorithm

Volume Status First-Line Treatment Second-Line Treatment
Hypovolemic Isotonic saline infusion Discontinue diuretics if applicable
Euvolemic Fluid restriction (<1 L/day) Consider vasopressin antagonists under close monitoring
Hypervolemic Fluid restriction + sodium restriction Treat underlying condition (heart failure, cirrhosis); consider loop diuretics [1]

Important Caveats

  • Avoid fluid restriction in neurosurgical patients at risk of vasospasm 1
  • Patients requiring urgent intervention to raise sodium for serious neurological symptoms should not receive tolvaptan 3
  • Following discontinuation of any treatment, monitor for rebound hyponatremia 1, 3
  • The optimal correction rate is no more than 8 mEq/L in 24 hours, with careful monitoring to avoid overcorrection 1

References

Guideline

Management of Severe Symptomatic Hyponatremia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.